PHG - Philips' Ventilator Device Recall Faces FDA's Continued Discontent Pressure | Benzinga
In its latest update on Koninklijke Philips NV's (NYSE: PHG) Respironics' June 2021 recall of certain CPAP, BiPAP, and ventilator devices, the FDA highlights ongoing concerns about the potential health risks from the devices' foam degradation.
Philips has been handling a Class I recall of certain respiratory devices since mid-2021 when its subsidiary Respironics recalled millions of ventilators, bi-level positive airway pressure (BiPAP), and continuous positive airway pressure (CPAP) machines.